These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 27215021)

  • 1. Synergisms of cardiovascular effects between iptakalim and amlodipine, hydrochlorothiazide or propranolol in anesthetized rats.
    Zhou HM; Zhong ML; Wang RH; Long CL; Zhang YF; Cui WY; Wang H
    Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2015 Nov; 31(6):532-40. PubMed ID: 27215021
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy and safety of olmesartan medoxomil and hydrochlorothiazide compared with benazepril and amlodipine besylate.
    Kereiakes DJ; Neutel JM; Punzi HA; Xu J; Lipka LJ; Dubiel R
    Am J Cardiovasc Drugs; 2007; 7(5):361-72. PubMed ID: 17953475
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and tolerability of combination therapy with valsartan plus hydrochlorothiazide compared with amlodipine monotherapy in hypertensive patients with other cardiovascular risk factors: the VAST study.
    Ruilope LM; Malacco E; Khder Y; Kandra A; Bönner G; Heintz D
    Clin Ther; 2005 May; 27(5):578-87. PubMed ID: 15978306
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of Different Antihypertensive Drug Combinations on Blood Pressure and Arterial Stiffness.
    Jatic Z; Skopljak A; Hebibovic S; Sukalo A; Rustempasic E; Valjevac A
    Med Arch; 2019 Jun; 73(3):157-162. PubMed ID: 31391706
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting hypertension with a new adenosine triphosphate-sensitive potassium channel opener iptakalim.
    Pan Z; Huang J; Cui W; Long C; Zhang Y; Wang H
    J Cardiovasc Pharmacol; 2010 Sep; 56(3):215-28. PubMed ID: 20410832
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tolerability and blood pressure-lowering efficacy of the combination of amlodipine plus valsartan compared with lisinopril plus hydrochlorothiazide in adult patients with stage 2 hypertension.
    Poldermans D; Glazes R; Kargiannis S; Wernsing M; Kaczor J; Chiang YT; Yen J; Gamboa R; Fomina I
    Clin Ther; 2007 Feb; 29(2):279-89. PubMed ID: 17472820
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Beneficial effects of the combination of amlodipine and losartan for lowering blood pressure in spontaneously hypertensive rats.
    Choi SM; Seo MJ; Kang KK; Kim JH; Ahn BO; Yoo M
    Arch Pharm Res; 2009 Mar; 32(3):353-8. PubMed ID: 19387578
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Medication of the month. Exforge HCT: combination of amlodipine besylate, valsartan and hydrochlorothiazide in a single tablet].
    Lancellotti P
    Rev Med Liege; 2010; 65(7-8):471-5. PubMed ID: 20857707
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and safety of olmesartan/amlodipine/hydrochlorothiazide in patients with hypertension not at goal with mono, dual or triple drug therapy: results of the CHAMPiOn study.
    Punzi HA
    Ther Adv Cardiovasc Dis; 2014 Feb; 8(1):12-21. PubMed ID: 24492985
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Benazepril combined with either amlodipine or hydrochlorothiazide is more effective than monotherapy for blood pressure control and prevention of end-organ injury in hypertensive Dahl rats.
    Zhou MS; Jaimes EA; Raij L
    J Cardiovasc Pharmacol; 2006 Jul; 48(1):857-61. PubMed ID: 16891915
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantitative model for the blood pressure-lowering interaction of valsartan and amlodipine.
    Heo YA; Holford N; Kim Y; Son M; Park K
    Br J Clin Pharmacol; 2016 Dec; 82(6):1557-1567. PubMed ID: 27504853
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of antihypertensive therapy on blood pressure control, cognition, and reactivity. A placebo-controlled comparison of prazosin, propranolol, and hydrochlorothiazide.
    Lasser NL; Nash J; Lasser VI; Hamill SJ; Batey DM
    Am J Med; 1989 Jan; 86(1B):98-103. PubMed ID: 2913779
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An 18-week, prospective, randomized, double-blind, multicenter study of amlodipine/ramipril combination versus amlodipine monotherapy in the treatment of hypertension: the assessment of combination therapy of amlodipine/ramipril (ATAR) study.
    Miranda RD; Mion D; Rocha JC; Kohlmann O; Gomes MA; Saraiva JF; Amodeo C; Filho BL
    Clin Ther; 2008 Sep; 30(9):1618-28. PubMed ID: 18840367
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [On the way to achieve hypertension treatment goals: results of the open observational program AESCULAP (exforge--clinical safety and efficiency of using a double combination of antihypertensive drugs in patients with uncontrolled blood pressure)].
    Chazova IE; Martynyuk TV
    Ter Arkh; 2013; 85(9):35-45. PubMed ID: 24261228
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synergistic effects of atenolol and amlodipine for lowering and stabilizing blood pressure in 2K1C renovascular hypertensive rats.
    Shen FM; Xie HH; Ling G; Xu LP; Su DF
    Acta Pharmacol Sin; 2005 Nov; 26(11):1303-8. PubMed ID: 16225751
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A new ATP-sensitive potassium channel opener reduces blood pressure and reverses cardiovascular remodeling in experimental hypertension.
    Wang H; Long CL; Zhang YL
    J Pharmacol Exp Ther; 2005 Mar; 312(3):1326-33. PubMed ID: 15525792
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differing contributions of the gut microbiota to the blood pressure lowering effects induced by first-line antihypertensive drugs.
    González-Correa C; Moleón J; Miñano S; Robles-Vera I; Toral M; Barranco AM; Martín-Morales N; O'Valle F; Guerra-Hernández E; Sánchez M; Gómez-Guzmán M; Jiménez R; Romero M; Duarte J
    Br J Pharmacol; 2024 Sep; 181(18):3420-3444. PubMed ID: 38770714
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Laboratory tests as predictors of the antihypertensive effects of amlodipine, bisoprolol, hydrochlorothiazide and losartan in men: results from the randomized, double-blind, crossover GENRES Study.
    Suonsyrjä T; Hannila-Handelberg T; Paavonen KJ; Miettinen HE; Donner K; Strandberg T; Tikkanen I; Tilvis R; Pentikäinen PJ; Kontula K; Hiltunen TP
    J Hypertens; 2008 Jun; 26(6):1250-6. PubMed ID: 18475165
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictors of systolic BP <140 mmHg and systolic BP level by randomly assigned treatment group (benazepril plus amlodipine or hydrochlorothiazide) in the ACCOMPLISH Study.
    Kjeldsen SE; Jamerson KA; Bakris GL; Pitt B; Dahlöf B; Velazquez EJ; Hua TA; Kelly RY; Zappe D; Hester A; Tuomilehto J; Ostergren J; Ibsen H; Weber M;
    Blood Press; 2012 Apr; 21(2):82-7. PubMed ID: 21830844
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and tolerability of aliskiren 300  mg/hydrochlorothiazide 25  mg (± amlodipine 5  mg) in hypertensive patients not controlled by candesartan 32  mg plus HCT 25  mg.
    Schweizer J; Ulmer HJ; Benduhn H; Klebs S
    Curr Med Res Opin; 2011 Jan; 27(1):131-40. PubMed ID: 21117946
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.